Cargando…
Coexisting EGFR and TP53 Mutations in Lung Adenocarcinoma Patients Are Associated With COMP and ITGB8 Upregulation and Poor Prognosis
The heterogeneity of lung adenocarcinoma is driven by key mutations in oncogenes. To determine the gene expression, single nucleotide polymorphisms, and co-mutations participating in the initiation and progression of lung adenocarcinoma, we comprehensively analyzed the data of 491 patients from The...
Autores principales: | Zheng, Chang, Li, Xuelian, Ren, Yangwu, Yin, Zhihua, Zhou, Baosen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056714/ https://www.ncbi.nlm.nih.gov/pubmed/32175330 http://dx.doi.org/10.3389/fmolb.2020.00030 |
Ejemplares similares
-
Upregulation of GNPNAT1 Predicts Poor Prognosis and Correlates With Immune Infiltration in Lung Adenocarcinoma
por: Liu, Wenting, et al.
Publicado: (2021) -
Prognostic Biomarker TP53 Mutations for Immune Checkpoint Blockade Therapy and Its Association With Tumor Microenvironment of Lung Adenocarcinoma
por: Lin, Xinqing, et al.
Publicado: (2020) -
Upregulation of circ_0008812 and circ_0001583 predicts poor prognosis and promotes breast cancer proliferation
por: Lin, Hong, et al.
Publicado: (2022) -
MiR-92a Family: A Novel Diagnostic Biomarker and Potential Therapeutic Target in Human Cancers
por: Jiang, Min, et al.
Publicado: (2019) -
Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities
por: Makgoo, Lilian, et al.
Publicado: (2022)